Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Colonization and immune modulation properties of Klebsiella pneumoniae biofilm-dispersed cells.

Guilhen C, Miquel S, Charbonnel N, Joseph L, Carrier G, Forestier C, Balestrino D.

NPJ Biofilms Microbiomes. 2019 Sep 24;5:25. doi: 10.1038/s41522-019-0098-1. eCollection 2019.

2.

Immunomodulatory effects of Lactobacillus plantarum on inflammatory response induced by Klebsiella pneumoniae.

Vareille-Delarbre M, Miquel S, Garcin S, Bertran T, Balestrino D, Evrard B, Forestier C.

Infect Immun. 2019 Sep 3. pii: IAI.00570-19. doi: 10.1128/IAI.00570-19. [Epub ahead of print]

PMID:
31481408
3.

Oral processing of hydrogels: Influence of food material properties versus individuals' eating capability.

Krop EM, Hetherington MM, Miquel S, Sarkar A.

J Texture Stud. 2019 Aug 27. doi: 10.1111/jtxs.12478. [Epub ahead of print]

PMID:
31454088
4.

A systematic review and meta-analysis of the effects of mastication on sustained attention in healthy adults.

Miquel S, Haddou MB, Day JEL.

Physiol Behav. 2019 Apr 1;202:101-115. doi: 10.1016/j.physbeh.2019.01.003. Epub 2019 Jan 3. Review.

PMID:
30611764
5.

Anaphylaxis Induced by Conlinin, a 2S Storage Protein in Flaxseed.

Basagaña M, Prieto-García A, Miquel S, Micozzi S, Bartolomé B, Labrador-Horrillo M, Roger A.

J Investig Allergol Clin Immunol. 2018;28(1):56-58. doi: 10.18176/jiaci.0208. No abstract available.

6.

Does reduced mastication influence cognitive and systemic health during aging?

Miquel S, Aspiras M, Day JEL.

Physiol Behav. 2018 May 1;188:239-250. doi: 10.1016/j.physbeh.2018.02.018. Epub 2018 Feb 13. Review.

PMID:
29452151
7.

Influence of oral processing on appetite and food intake - A systematic review and meta-analysis.

Krop EM, Hetherington MM, Nekitsing C, Miquel S, Postelnicu L, Sarkar A.

Appetite. 2018 Jun 1;125:253-269. doi: 10.1016/j.appet.2018.01.018. Epub 2018 Feb 22.

8.

Immunotheraphy in Allergic Diseases.

Roger A, Basagana M, Teniente-Serra A, Depreux N, Jurgens Y, Padro C, Miquel S, Elduque C, Martinez-Caceres EM.

Curr Pharm Des. 2018;24(11):1174-1194. doi: 10.2174/1381612824666180116094048. Review.

PMID:
29336248
9.

Poor cognitive ageing: Vulnerabilities, mechanisms and the impact of nutritional interventions.

Miquel S, Champ C, Day J, Aarts E, Bahr BA, Bakker M, Bánáti D, Calabrese V, Cederholm T, Cryan J, Dye L, Farrimond JA, Korosi A, Layé S, Maudsley S, Milenkovic D, Mohajeri MH, Sijben J, Solomon A, Spencer JPE, Thuret S, Vanden Berghe W, Vauzour D, Vellas B, Wesnes K, Willatts P, Wittenberg R, Geurts L.

Ageing Res Rev. 2018 Mar;42:40-55. doi: 10.1016/j.arr.2017.12.004. Epub 2017 Dec 15. Review.

10.

Opposing effect of Lactobacillus on in vitro Klebsiella pneumoniae in biofilm and in an in vivo intestinal colonisation model.

Lagrafeuille R, Miquel S, Balestrino D, Vareille-Delarbre M, Chain F, Langella P, Forestier C.

Benef Microbes. 2018 Jan 29;9(1):87-100. doi: 10.3920/BM2017.0002. Epub 2017 Oct 12.

PMID:
29022382
11.

New Insights into the Diversity of the Genus Faecalibacterium.

Benevides L, Burman S, Martin R, Robert V, Thomas M, Miquel S, Chain F, Sokol H, Bermudez-Humaran LG, Morrison M, Langella P, Azevedo VA, Chatel JM, Soares S.

Front Microbiol. 2017 Sep 22;8:1790. doi: 10.3389/fmicb.2017.01790. eCollection 2017.

12.

Using murine colitis models to analyze probiotics-host interactions.

Martín R, Chain F, Miquel S, Motta JP, Vergnolle N, Sokol H, Langella P.

FEMS Microbiol Rev. 2017 Aug 1;41(Supp_1):S49-S70. doi: 10.1093/femsre/fux035. Review.

PMID:
28830096
13.

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic.

Martín R, Miquel S, Benevides L, Bridonneau C, Robert V, Hudault S, Chain F, Berteau O, Azevedo V, Chatel JM, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Front Microbiol. 2017 Jun 30;8:1226. doi: 10.3389/fmicb.2017.01226. eCollection 2017.

14.

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice.

Martín R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, van Hylckama Vlieg J, Bermudez-Humaran LG, Smokvina T, Langella P.

Front Microbiol. 2016 May 6;7:608. doi: 10.3389/fmicb.2016.00608. eCollection 2016.

15.

Anti-biofilm Activity as a Health Issue.

Miquel S, Lagrafeuille R, Souweine B, Forestier C.

Front Microbiol. 2016 Apr 26;7:592. doi: 10.3389/fmicb.2016.00592. eCollection 2016. Review.

16.

Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.

Miquel S, Martín R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Bermúdez-Humarán LG, Sokol H, Thomas M, Theodorou V, Langella P, Carvalho FA.

Sci Rep. 2016 Jan 18;6:19399. doi: 10.1038/srep19399.

17.

Lipid-rich diet enhances L-cell density in obese subjects and in mice through improved L-cell differentiation.

Aranias T, Grosfeld A, Poitou C, Omar AA, Le Gall M, Miquel S, Garbin K, Ribeiro A, Bouillot JL, Bado A, Brot-Laroche E, Clément K, Leturque A, Guilmeau S, Serradas P.

J Nutr Sci. 2015 May 20;4:e22. doi: 10.1017/jns.2015.11. eCollection 2015.

18.

Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.

Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermúdez-Humarán LG, Pigneur B, Lequin O, Kharrat P, Thomas G, Rainteau D, Aubry C, Breyner N, Afonso C, Lavielle S, Grill JP, Chassaing G, Chatel JM, Trugnan G, Xavier R, Langella P, Sokol H, Seksik P.

Gut. 2016 Mar;65(3):415-425. doi: 10.1136/gutjnl-2014-307649. Epub 2015 Jun 4.

19.

Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.

Miquel S, Leclerc M, Martin R, Chain F, Lenoir M, Raguideau S, Hudault S, Bridonneau C, Northen T, Bowen B, Bermúdez-Humarán LG, Sokol H, Thomas M, Langella P.

MBio. 2015 Apr 21;6(2). pii: e00300-15. doi: 10.1128/mBio.00300-15.

20.

A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe.

Miquel S, Beaumont M, Martín R, Langella P, Braesco V, Thomas M.

Microb Cell Fact. 2015 Apr 9;14:48. doi: 10.1186/s12934-015-0229-1. Review.

21.

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermúdez-Humarán LG.

BMC Microbiol. 2015 Mar 21;15:67. doi: 10.1186/s12866-015-0400-1.

22.

Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.

Laval L, Martin R, Natividad JN, Chain F, Miquel S, Desclée de Maredsous C, Capronnier S, Sokol H, Verdu EF, van Hylckama Vlieg JE, Bermúdez-Humarán LG, Smokvina T, Langella P.

Gut Microbes. 2015;6(1):1-9. doi: 10.4161/19490976.2014.990784. Epub 2015 Jan 14.

23.

In Memoriam, Arlette Darfeuille-Michaud, PhD.

Raisch J, Sivignon A, Chassaing B, Lapaquette P, Miquel S, Carvalho F, Rolhion N, Bringer MA, Barnich N, Boudeau J, Di Martino P.

Gastroenterology. 2014 Nov;147(5):943-4. doi: 10.1053/j.gastro.2014.08.009. Epub 2014 Oct 21. No abstract available.

PMID:
25438798
24.

In Memoriam, Arlette Darfeuille-Michaud, PhD.

Raisch J, Sivignon A, Chassaing B, Lapaquette P, Miquel S, Carvalho F, Rolhion N, Bringer MA, Barnich N, Boudeau J, Di Martino P.

Gut. 2014 Nov;63(11):1681-2. doi: 10.1136/gutjnl-2014-308182. No abstract available.

PMID:
25281328
25.

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG.

Hum Vaccin Immunother. 2014;10(6):1611-21. doi: 10.4161/hv.28549. Epub 2014 Apr 14.

26.

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Miquel S, Martín R, Bridonneau C, Robert V, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Gut Microbes. 2014 Mar-Apr;5(2):146-51. doi: 10.4161/gmic.27651. Epub 2014 Jan 22.

27.

Gut ecosystem: how microbes help us.

Martín R, Miquel S, Ulmer J, Langella P, Bermúdez-Humarán LG.

Benef Microbes. 2014 Sep;5(3):219-33. doi: 10.3920/BM2013.0057. Review.

PMID:
24583612
28.

The role of metagenomics in understanding the human microbiome in health and disease.

Martín R, Miquel S, Langella P, Bermúdez-Humarán LG.

Virulence. 2014 Apr 1;5(3):413-23. doi: 10.4161/viru.27864. Epub 2014 Feb 11. Review.

29.

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.

Martín R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, Verdu EF, Bercik P, Bermúdez-Humarán LG, Langella P.

Inflamm Bowel Dis. 2014 Mar;20(3):417-30. doi: 10.1097/01.MIB.0000440815.76627.64.

PMID:
24418903
30.

Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease.

Martín R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermúdez-Humarán LG.

Microb Cell Fact. 2013 Jul 23;12:71. doi: 10.1186/1475-2859-12-71. Review.

31.

Faecalibacterium prausnitzii and human intestinal health.

Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P.

Curr Opin Microbiol. 2013 Jun;16(3):255-61. doi: 10.1016/j.mib.2013.06.003. Epub 2013 Jul 3. Review.

PMID:
23831042
32.

Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent.

Wrzosek L, Miquel S, Noordine ML, Bouet S, Joncquel Chevalier-Curt M, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C, Langella P, Thomas M.

BMC Biol. 2013 May 21;11:61. doi: 10.1186/1741-7007-11-61.

33.

Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82.

Miquel S, Peyretaillade E, Claret L, de Vallée A, Dossat C, Vacherie B, Zineb el H, Segurens B, Barbe V, Sauvanet P, Neut C, Colombel JF, Medigue C, Mojica FJ, Peyret P, Bonnet R, Darfeuille-Michaud A.

PLoS One. 2010 Sep 17;5(9). pii: e12714. doi: 10.1371/journal.pone.0012714.

34.

Role of decreased levels of Fis histone-like protein in Crohn's disease-associated adherent invasive Escherichia coli LF82 bacteria interacting with intestinal epithelial cells.

Miquel S, Claret L, Bonnet R, Dorboz I, Barnich N, Darfeuille-Michaud A.

J Bacteriol. 2010 Apr;192(7):1832-43. doi: 10.1128/JB.01679-09. Epub 2010 Jan 29.

35.

Extension of sensitivity and uncertainty analysis for long term dose assessment of high level nuclear waste disposal sites to uncertainties in the human behaviour.

Albrecht A, Miquel S.

J Environ Radioact. 2010 Jan;101(1):55-67. doi: 10.1016/j.jenvrad.2009.08.012. Epub 2009 Sep 16.

PMID:
19758732
36.

The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway.

Claret L, Miquel S, Vieille N, Ryjenkov DA, Gomelsky M, Darfeuille-Michaud A.

J Biol Chem. 2007 Nov 16;282(46):33275-83. Epub 2007 Sep 7.

Supplemental Content

Loading ...
Support Center